These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11401092)

  • 21. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular manifestations of graft versus host disease following bone marrow transplantation.
    Claes K; Kestelyn P
    Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM).
    Socié G; Cahn JY; Carmelo J; Vernant JP; Jouet JP; Ifrah N; Milpied N; Michallet M; Lioure B; Pico JL; Witz F; Molina L; Fischer A; Bardou VJ; Gluckman E; Reiffers J
    Br J Haematol; 1997 Jun; 97(4):865-70. PubMed ID: 9217190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels.
    Imamura M; Hashino S; Kobayashi S; Kobayashi H; Tanaka J; Imai K; Kasai M; Sakurada K; Miyazaki T
    Int J Hematol; 1994 Jul; 60(1):85-9. PubMed ID: 7919241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
    Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
    Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
    Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
    Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Saso R; Mehta J
    Leuk Lymphoma; 1999 Feb; 32(5-6):505-12. PubMed ID: 10048423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis.
    Wakae T; Takatsuka H; Seto Y; Iwata N; Mori A; Okada M; Fujimori Y; Okamoto T; Kakishita E; Hara H
    Hematology; 2002 Oct; 7(5):305-10. PubMed ID: 12850818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single course of remission reinduction chemotherapy for acute myelogenous leukemia relapsing after allogeneic bone marrow transplantation is complicated by graft-versus-host disease and followed by sustained complete remission.
    Vandenberghe P; Verhoef GE; Emonds MP; Demuynck H; Zachée P; De Wolf-Peeters C; Decorte R; Cassiman JJ; Boogaerts MA
    Leukemia; 1997 Oct; 11(10):1775-8. PubMed ID: 9324300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical acute graft-versus-host disease.
    Shin J; Hong W; Song H; Choi G; Kim YC
    Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission.
    Saarinen-Pihkala UM; Gustafsson G; Ringdén O; Heilmann C; Glomstein A; Lönnerholm G; Abrahamsson J; Bekassy AN; Schroeder H; Mellander L;
    J Clin Oncol; 2001 Jul; 19(14):3406-14. PubMed ID: 11454889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation.
    Ogawa H; Soma T; Hosen N; Tatekawa T; Tsuboi A; Oji Y; Tamaki H; Kawakami M; Ikegame K; Murakami M; Fujioka T; Kim EH; Oka Y; Sugiyama H
    Transplantation; 2002 Jul; 74(2):236-43. PubMed ID: 12151737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of HGF on GVHD and Th1/Th2-related cytokines in ALL mice after allo-BMT].
    Xia YJ; Gao QP; Wan CC; Cheng FJ; Wang WM; Guo RC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):35-8. PubMed ID: 15748432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
    Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
    Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
    Kikuta A; Suzuki H
    Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.